Form 8-K - Current report:
SEC Accession No. 0001213900-24-065203
Filing Date
2024-08-05
Accepted
2024-08-05 16:35:33
Documents
14
Period of Report
2024-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea021063001-8k_anewmed.htm   iXBRL 8-K 26440
  Complete submission text file 0001213900-24-065203.txt   242896

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE wena-20240730.xsd EX-101.SCH 3485
3 XBRL DEFINITION FILE wena-20240730_def.xml EX-101.DEF 26508
4 XBRL LABEL FILE wena-20240730_lab.xml EX-101.LAB 36424
5 XBRL PRESENTATION FILE wena-20240730_pre.xml EX-101.PRE 25132
16 EXTRACTED XBRL INSTANCE DOCUMENT ea021063001-8k_anewmed_htm.xml XML 5470
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
ANEW Medical, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241175343
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)